VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Dr. Sandler on Candidates for Liase Inhibitor Clinical Trials

Howard M. Sandler, MD
Published: Tuesday, Mar 29, 2011

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, discusses candidates for liase inhibitor clinical trials, the trial would look at gleason 8 or 9 tumors, locally advanced, T3 tumors that extend outside of the prostate. These are generally men who are not candidates for surgery and would benefit from other options.

Howard M. Sandler, MD, MS, from Cedars-Sinai Medical Center, discusses candidates for liase inhibitor clinical trials, the trial would look at gleason 8 or 9 tumors, locally advanced, T3 tumors that extend outside of the prostate. These are generally men who are not candidates for surgery and would benefit from other options.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x